The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Systemic Sclerosis: Demographic, Clinical, and Serologic Features and Survival in 1,012 Italian Patients
Open accessAbstract
Introduction Systemic sclerosis (SSc) is a connective tissue disease clinically characterized by different degrees of skin fibrosis and visceral organ involvement (17,19,22). The etiology of SSc remains obscure; the disease appears to be the result of a multistep and multifactorial process, including immune system alterations, genetic and exogenous, and toxic or infectious factors (17,19,22). The epidemiology of SSc is not definitely established due to the relative rarity of the disease, the difficulty in diagnosis, and its extreme clinical variability. SSc affects females more frequently than males, with a peak of incidence between ages 45 and 64 years (19,22). There seems to be an increased incidence of the disease in blacks, particularly in black females, but no other significant racial differences in distribution. Various HLA studies in SSc patients failed to identify any clearcut associations, even if a role of specific HLA antigens might be hypothesized for particular clinico-serologic SSc subsets (19). Moreover, familial factors are certainly important for SSc development: it is not rare to observe a scleroderma patient with 1 or more firstdegree relatives with another autoimmune systemic disorder, such as Raynaud phenomenon, systemic lupus, or rheumatoid arthritis (19,22). The annual incidence (new cases/population at risk per year) of SSc varies largely among different surveys (from 0.6 to 19.1 per million/year), as does the estimated prevalence (number of cases living at a particular time or during a given time interval per million of population at risk: from 126 to 1,500). The actual incidence and prevalence of the disease are generally underestimated; the minimum estimated values are 20/million per year and 1,500/million, respectively. The number of undiagnosed cases, especially in the oldest surveys, might be significant; this is due, at least in part, to the clinical characteristics of the disease. SSc includes a wide spectrum of symptoms, varying from very mild cutaneous and internal organ involvement to diffuse fibrosis responsible for organ failure (4,11,17,19,22). A variable combination of organ damage, or, less frequently, a severe, single organ involvement, is responsible for SSc morbidity and mortality. Among different connective tissue diseases, SSc shows the poorest prognosis (17,19,22). The availability of well-recognized criteria for diagnosis, disease activity (34), and severity (21), as well as of valuable prognostic parameters, should be decisive for timely patient identification, clinical assessment, and management. In the absence of valuable diagnostic criteria, patients are usually classified according to the American College of Rheumatology (formerly ARA) preliminary criteria for SSc classification (32) (Table 1). The introduction of capillaroscopic SSc pattern (capillary dilation with or without capillary dropouts) and SSc-related serum autoantibodies might improve the usefulness of classification criteria, particularly in discriminating the early stage of the disease. However, these criteria are not intended to assist in the diagnosis of individual patients, which is based on the careful observation of different clinical and laboratory features.TABLE 1: Classification criteria and diagnostic parameters of systemic sclerosis (SSc)Diagnosis of SSc in patients with diffuse cutaneous sclerosis is quite easy; on the contrary, it can be particularly difficult during the early stage of the disease or in the presence of sine scleroderma SSc (ssSSc) (Figure 1). In these instances, isolated Raynaud phenomenon (Table 2) or other connective tissue diseases must be ruled out. Diagnosis of SSc is currently based on the presence of cutaneous manifestations (symmetrical, truncal, and/or acral skin sclerosis, skin ulcers, digital pitting scars, telangiectasias, calcinosis), typical internal organ involvement (lung fibrosis, esophageal dysfunction, heart and/or renal alterations), capillaroscopic scleroderma pattern, and autoantibody profile (see Table 1, Figures 1–3).TABLE 2: Approach to apparently isolated Raynaud phenomenonFig. 1: Systemic sclerosis (SSc) classification according to skin sclerosis extent (black areas). Sine scleroderma SSc (ssSSc): absence of cutaneous sclerosis in patients with typical SSc visceral organ involvement, capillaroscopic changes, and serum autoantibodies. Limited cutaneous scleroderma (lcSSc): skin sclerosis of fingers (sclerodactyly) with or without mild sclerotic lesions at neck, face, and armpits. Intermediate cutaneous scleroderma (icSSc): sclerosis of upper and lower limbs, neck and face, without truncal involvement. Diffuse cutaneous scleroderma (dcSSc): distal and truncal skin sclerosis.Fig. 2: Capillaroscopic findings. a. Normal subject. b. Patient with isolated Raynaud phenomenon. c. and d. Typical scleroderma patterns:c. diffuse capillary enlargement (megacapillaries), d. presence of megacapillaries and large avascular areas (capillary dropouts).Fig
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-95 · Cited by 3,950
Steen, V. D., Powell, D. L., & Medsger, T. A. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310207 · Cited by 573
A disease severity scale for systemic sclerosis: development and testing.
Medsger, T. A., Silman, A. J., Steen, V. D., Black, C. M., Åkesson, A., Bacon, P. A., Harris, C. A., Jablonska, S., Jayson, M. I. V., Jiménez, S. A., et al. (1999) · PubMed · Cited by 442
White, B., Moore, W. C., Wigley, F. M., Xiao, H. Q., & Wise, R. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-12-200006200-00004 · Cited by 384
MEDSGER, T. A., MASI, A. T., RODNAN, G. P., BENEDEK, T. G., & ROBINSON, H. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-75-3-369 · Cited by 321
Long-Term Outcomes of Scleroderma Renal Crisis
Steen, V. D., & Medsger, T. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00010 · Cited by 321
Predictors of survival in systemic sclerosis (Scleroderma)
Altman, R. D., Medsger, T. A., Bloch, D. A., & Michel, B. A. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340405 · Cited by 298
Mortality and causes of death in a Swedish series of systemic sclerosis patients
Hesselstrand, R., Scheja, A., & Åkesson, A. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.11.682 · Cited by 247
Giordano, M., Valentini, G., Migliaresi, S., et al. (1986) · PubMed · Cited by 196
Self-citation
Cited by
Changes in causes of death in systemic sclerosis, 1972–2002
Steen, V. D., & Medsger, T. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066068 · Cited by 1,528
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Interstitial Lung Disease in Systemic Sclerosis: A Simple Staging System
Goh, N. S. L., Desai, S. R., Veeraraghavan, S., Hansell, D. M., Copley, S. J., Maher, T. M., Corte, T. J., Sander, C. R., Ratoff, J., Devaraj, A., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-877oc · Cited by 1,230
Mayes, M. D., Lacey, J. V., Beebe‐Dimmer, J., Gillespie, B. W., Cooper, B., Laing, T. J., & Schottenfeld, D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11073 · Cited by 935
Korn, J. H., Mayes, M., Matucci Cerinic, M., Rainisio, M., Pope, J., Hachulla, E., Rich, E., Carpentier, P., Molitor, J., Seibold, J. R., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20676 · Cited by 728
Metadata
- Authors
- FERRI, C., VALENTINI, G., COZZI, F., SEBASTIANI, M., MICHELASSI, C., LA MONTAGNA, G., BULLO, A., CAZZATO, M., TIRRI, E., STORINO, F., GIUGGIOLI, D., CUOMO, G., ROSADA, M., BOMBARDIERI, S., TODESCO, S., & TIRRI, G.
- Venue
- Medicine
- Published
- 2002-03
- Volume
- 81
- Issue
- 2
- Pages
- 139-153
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2017990928
- Cited by
- 764
- References
- 20
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systemic Sclerosis: Demographic, Clinical, and Serologic Features and Survival in 1,012 Italian Patients. https://app.cochat.ai/papers/10.1097/00005792-200203000-00004
- The paper
- FERRI, C., VALENTINI, G., COZZI, F., SEBASTIANI, M., MICHELASSI, C., LA MONTAGNA, G., BULLO, A., CAZZATO, M., TIRRI, E., STORINO, F., GIUGGIOLI, D., CUOMO, G., ROSADA, M., BOMBARDIERI, S., TODESCO, S., & TIRRI, G. (2002). Systemic Sclerosis: Demographic, Clinical, and Serologic Features and Survival in 1,012 Italian Patients. Medicine. https://doi.org/10.1097/00005792-200203000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.